Prepaid Expenses, Deposits, and Other Current and Non-Current Assets

12 Months Ended

Dec. 31, 2021

Prepaid Expenses Deposits And Other Current And Non-current Assets

Prepaid Expenses, Deposits, and Other Current and Non-Current Assets

Note 7 — Prepaid Expenses, Deposits, and Other Current and Non-Current Assets

Current Assets

Prepaid expenses and other current assets consisted of the following as of:

	December 31, 2021		December 31, 2020
Advanced payments to service providers and suppliers	$	2,084	$	507
Prepaid insurance		1,856		61
Deposits		713		262
EsoCheck cell collection supplies		434		779
EsoGuard mailer supplies		59		55
CarpX devices		33		21
Total prepaid expenses, deposits and other current assets	$	5,179	$	1,685

Non-Current Assets

The Company, through its majority-owned subsidiary Lucid Diagnostics Inc., entered into an agreement with a clinical research organization (“CRO”) in connection with EsoGuard clinical trials (the “EsoGuard CRO Agreement”). The term of the EsoGuard CRO Agreement is from the September 2019 effective date to the conclusion of the respective clinical trials, but not to exceed 60 months from the effective date of the EsoGuard CRO Agreement. The CRO agreement may be cancelled with sixty days written notice, without an early termination fee. The Company incurred an on-account deposit of $725 and $755 as of December 31, 2021 and 2020, respectively, with the deposit classified as a non-current asset in the line item captioned “Other assets” on the accompanying consolidated balance sheets as of December 31, 2021 and 2020. See Note 11, Commitment and Contingencies, for a discussion of the EsoGuard CRO Agreement.